The arrival of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable buzz within the healthcare community. This novel dual GIP and GLP-1 agonist medication seems to deliver notable improvements in body shedding compared to current therapies. Initial research studies have shown substantial decreases in body fat percentage, conceiva